Journal for ImmunoTherapy of Cancer
Open Access
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ 
SJR
- PublisherBMJ PUBLISHING GROUP
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesUSD 2885
- Publication Time18
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- Society/Institute/SponsorSociety for Immunotherapy of Cancer
- FrequencyContinuous publication
- Publication Start Year2013
- Publisher URL
- Website URL
- Other charges
- Plagiarism
- Publication Time18
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- Deposit PolicySherpa/Romeo
- License typeCC BY-NC, CC BY, CC BY-NC-ND
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Journal for ImmunoTherapy of Cancer been publishing? 
The Journal for ImmunoTherapy of Cancer has been publishing since 2013 till date.
How frequently is the Journal for ImmunoTherapy of Cancer published?
Journal for ImmunoTherapy of Cancer is published Continuous publication.
Who is the publisher of Journal for ImmunoTherapy of Cancer?
The publisher of Journal for ImmunoTherapy of Cancer is BMJ PUBLISHING GROUP.
How can I view the journal metrics of Journal for ImmunoTherapy of Cancer on editage?
For the Journal for ImmunoTherapy of Cancer metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Journal for ImmunoTherapy of Cancer?
The eISSN number is 2051-1426 and pISSN number is 2051-1426 for Journal for ImmunoTherapy of Cancer.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Cancer, Immunotherapy, Lung cancer, Immune checkpoint, Gene expression, Progression-free survival, Melanoma, Tumor growth, Overall survival, Body mass index, Phagocytosis, Antigen, Chemokine, Toxicity, Immune effector, Surgical resection, Chimeric antigen receptor, Antitumor immunity, Lung, Tumor microenvironment.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.